AARD vs GM · $284.4M cap vs P/E 7.5, rev $91.65B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus General Motors Company (GM) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported GM revenue for 2026-06-30 was $91.65B. Net income was $3.93B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
AARD currently screens at market cap $284.4M. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Not investment advice. Open the AARD and GM stock pages for the full models.
Not investment advice.